| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CB | Common Shares | Sale | -$318K | -1.24K | -1.28% | $256.93 | 95.3K | Mar 15, 2024 | Direct | |
| transaction | CB | Common Shares | Options Exercise | $1.5M | +13.1K | +13.72% | $114.78 | 108K | Mar 15, 2024 | Direct | |
| transaction | CB | Common Shares | Sale | -$3.13M | -12.2K | -11.26% | $256.95 | 96.1K | Mar 15, 2024 | Direct | F1 |
| transaction | CB | Common Shares | Options Exercise | $1.7M | +14.4K | +14.94% | $118.39 | 110K | Mar 15, 2024 | Direct | |
| transaction | CB | Common Shares | Sale | -$3.47M | -13.5K | -12.23% | $257.10 | 97K | Mar 15, 2024 | Direct | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CB | Options to Acquire Common Shares | Options Exercise | $0 | -13.1K | -12.74% | $0.00 | 89.5K | Mar 15, 2024 | Common Shares | 13.1K | $114.78 | Direct | F3, F4 |
| transaction | CB | Options to Acquire Common Shares | Options Exercise | $0 | -14.4K | -16.04% | $0.00 | 75.1K | Mar 15, 2024 | Common Shares | 14.4K | $118.39 | Direct | F4, F5 |
| Id | Content |
|---|---|
| F1 | The Common Shares reported herein as being sold were sold at a range of between $256.860 and $257.081 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such price range. |
| F2 | The Common Shares reported herein as being sold were sold at a range of between $256.998 and $257.181 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such price range. |
| F3 | Options vested as follows: 1/3 on February 26, 2016, 1/3 on February 26, 2017 and 1/3 on February 26, 2018. |
| F4 | All options of this tranche have been exercised. Total includes options from other tranches with different exercise prices, vesting and expiration dates. |
| F5 | Options vested as follows: 1/3 on February 25, 2017, 1/3 on February 25, 2018 and 1/3 on February 25, 2019. |
*General Counsel